The contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%
Roots Analysis has done a detailedstudy on Biologics Fill /Finish Services Market, 2019-2030, covering keyaspects of the industry’s evolution and identifying potential future growthopportunities.
To order this 480+page report, which features 237 figures and 267 tables, please visit this link
Key Market Insights
§ Over 115 companieslocated in various regions across the globe claim to provide contract fill /finish services for various types of biopharmaceutical drug / therapy products
§ The market landscapefeatures a mix of both established players and new entrants; multiple biologicsfill / finish service providers based in developed geographies have alreadyadopted advanced fill / finish technologies
§ Vials represent the most prominent form of packaging used forbiopharmaceutical interventions; with increasing demand for self-administrationdevices, syringes have also garnered significant attention
§ In fact, to acquire competenciesacross the value chain, stakeholders have actively invested in expanding theirexisting infrastructure and capabilities to cater to the evolving needs of bothindigenous and international clients
§ Over the past six years, the fill / finish services domain has alsowitnessed significant partnership activity, with companies building strategicbusiness relationships to consolidate their positions in the market
§ The outcome ofconsolidation is evident from our proprietary competitiveness analysis, basedon several relevant parameters highlighting service and supplier strengths
§ Presently, theinstalled global contract fill / finish capacity, across various geographies,is estimated to be over 17 million units (in term of packaging containers)
§ The demand forcontract fill / finish services for biologics is expected to increase in thecoming years; it is likely that stakeholders will have to expand theirrespective capacities to ensure consistent supply
§ We expectbiopharmaceutical developers to continue to outsource their fill / finishoperations in the short to mid-term, resulting in an annualized growth rate ofmore than 10%
§ In the long-term, theprojected opportunity is anticipated to be well distributed across varioustypes of primary packaging, biological interventions and target diseaseindications
For more information, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html
Table of Contents
1. PREFACE
1.1. Scopeof the Report
1.2. ResearchMethodology
1.3. ChapterOutlines
2. EXECUTIVESUMMARY
3. INTRODUCTION
3.1. ChapterOverview
3.2. Introductionto Biologics
3.3. Needfor Outsourcing Biologics-related Operations
3.4. Introductionto Contract Manufacturing
3.5. CommonlyOutsourced Operations in the Biopharmaceutical Industry
3.5.1. BiologicsFill / Finish Operations
3.6. BasicGuidelines for Selecting a Fill / Finish Service Provider
3.7. Advantagesof Outsourcing Fill / Finish Services
3.8. Risksand Challenges of Outsourcing Fill / Finish Operations
4. COMPETITIVELANDSCAPE
4.1. ChapterOverview
4.2. BiologicsFill / Finish Service Providers: Overall Market Landscape
4.2.1. Analysisby Year of Establishment
4.2.2. Analysisby Company Size
4.2.3. Analysisby Location of Headquarters
4.2.4. Analysisby Location of Fill / Finish Facilities
4.2.5. Analysisby Type of Packaging
4.2.6. Analysisby Additional Services Offered
4.2.7. Analysisby Scale of Operation
4.2.8. Analysisby Type of Biologics Filled
5. COMPANYCOMPETITIVENESS ANALYSIS
5.1. ChapterOverview
5.2. Methodology
5.3. Assumptionsand Key Input Parameters
5.4. CompetitivenessAnalysis: Biologics Fill / Finish Service Providers in North America
5.4.1. CompaniesOffering Fill / Finish Services for Ampoules
5.4.2. CompaniesOffering Fill / Finish Services for Cartridges
5.4.3. CompaniesOffering Fill / Finish Services for Syringes
5.4.4. CompaniesOffering Fill / Finish Services for Vials
5.5. CompetitivenessAnalysis: Fill / Finish Service Providers in Europe
5.5.1. CompaniesOffering Fill / Finish Services for Ampoules
5.5.2. CompaniesOffering Fill / Finish Services for Cartridges
5.5.3. CompaniesOffering Fill / Finish Services for Syringes
5.5.4. CompaniesOffering Fill / Finish Services for Vials
5.6. CompetitivenessAnalysis: Fill / Finish Service Providers of Asia-Pacific
5.6.1. CompaniesOffering Fill / Finish Services for Ampoules
5.6.2. CompaniesOffering Fill / Finish Services for Cartridges
5.6.3. CompaniesOffering Fill / Finish Services for Syringes
5.6.4. CompaniesOffering Fill / Finish Services for Vials
6. BIOLOGICSFILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES
6.1. ChapterOverview
6.2. AdvancedBioScience Laboratories (ABL)
6.2.1. CompanyOverview
6.2.2. ServicePortfolio
6.2.3. RecentDevelopments
6.2.4. FutureOutlook
6.3. Albany MolecularResearch (AMRI)
6.3.1. CompanyOverview
6.3.2. ServicePortfolio
6.3.3. FinancialInformation
6.3.4. RecentDevelopments
6.3.5. FutureOutlook
6.4. BioPharmaSolutions
6.4.1. CompanyOverview
6.4.2. ServicePortfolio
6.4.3. FinancialInformation
6.4.4. RecentDevelopments
6.4.5. FutureOutlook
6.5. BioReliance
6.5.1. CompanyOverview
6.5.2. ServicePortfolio
6.5.3. FinancialInformation
6.5.4. RecentDevelopments
6.5.5. FutureOutlook
6.6. EmergentBioSolutions
6.6.1. Company Overview
6.6.2. ServicePortfolio
6.6.3. FinancialInformation
6.6.4. RecentDevelopments
6.6.5. FutureOutlook
6.7. Patheon
6.7.1. CompanyOverview
6.7.2. ServicesPortfolio
6.7.3. FinancialInformation
6.7.4. RecentDevelopments
6.7.5. FutureOutlook
7. BIOLOGICSFILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES
7.1. ChapterOverview
7.2. BoehringerIngelheim BioXcellence
7.2.1. CompanyOverview
7.2.2. ServicePortfolio
7.2.3. FinancialInformation
7.2.4. RecentDevelopments
7.2.5. FutureOutlook
7.3. IDTBiologika
7.3.1. CompanyOverview
7.3.2. ServicePortfolio
7.3.3. RecentDevelopments
7.3.4. FutureOutlook
7.4. Lonza
7.4.1. CompanyOverview
7.4.2. ServicePortfolio
7.4.3. FinancialInformation
7.4.4. Recent Developments
7.4.5. FutureOutlook
7.5. Recipharm
7.5.1. CompanyOverview
7.5.2. ServicePortfolio
7.5.3. FinancialInformation
7.5.3. RecentDevelopments
7.5.4. FutureOutlook
7.6. VetterPharma
7.6.1. CompanyOverview
7.6.2. ServicePortfolio
7.6.3. RecentDevelopments
7.6.4. FutureOutlook
8. BIOLOGICSFILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES
8.1. ChapterOverview
8.2. Biocon
8.2.1. CompanyOverview
8.2.2. ServicePortfolio
8.2.3. FinancialInformation
8.2.4. RecentDevelopments
8.2.5. FutureOutlook
8.3. ChemPartner
8.3.1. CompanyOverview
8.3.2. ServicePortfolio
8.3.3. RecentDevelopments
8.3.4. FutureOutlook
8.4. LuinaBio
8.4.1. CompanyOverview
8.4.2. ServicePortfolio
8.4.3. RecentDevelopments
8.4.4. FutureOutlook
8.5. MycenaxBiotech
8.5.1. CompanyOverview
8.5.2. ServicePortfolio
8.5.3. FinancialInformation
8.5.3. RecentDevelopments
8.5.4. FutureOutlook
8.6. WuxiBiologics
8.6.1. CompanyOverview
8.6.2. ServicePortfolio
8.6.3. FinancialInformation
8.6.4. RecentDevelopments
8.6.4. FutureOutlook
9. PARTNERSHIPSAND COLLABORATIONS
9.1. ChapterOverview
9.2. PartnershipModels
9.3. BiologicsFill / Finish Service Providers: List of Partnerships and Collaborations
9.3.1. Analysisby Year of Partnership
9.3.2. Analysisby Type of Partnership
9.3.3. Analysisby Type of Service
9.3.4. Analysisby Scale of Operation
9.3.5. Analysisby Type of Biologic
9.3.6. Analysisby Geographical Location
9.3.7. MostActive Players: Analysis by Number of Partnerships
9.3.8. ServiceAlliances and Supply Agreements: Analysis by Type of Service
9.3.9. Acquisitionsand Mergers: Analysis by Type of Service
10. RECENTEXPANSIONS
10.1. ChapterOverview
10.2. BiologicsFill / Finish Service Providers: Recent Expansions
10.2.1. Analysisby Year of Expansion
10.2.2. Analysisby Type of Expansion
10.2.3. Analysisby Type of Packaging
10.2.4. Analysisby Type of Service
10.2.5. Analysisby Type of Biologic
10.2.6. Analysisby Type of Biologic and Scale of Operation
10.2.7. Analysisby Geographical Location
10.2.8. MostActive Players: Analysis by Type of Service and Type of Biologic
10.2.9. Expansionsin North America: Analysis by Type of Service and Type of
Biologic
10.2.10. Expansionsin Europe: Analysis by Type of Service and Type of Biologic
10.2.11. Expansionsin Asia-Pacific: Analysis by Type of Service and Type of Biologic
11. CAPACITYANALYSIS
11.1. Chapter Overview
11.2. Assumptionsand Methodology
11.3. Global Installed Fill / Finish Capacity(by Number of Units)
11.3.1. Analysisby Type of Packaging
11.3.2. Analysisby Size of Manufacturer
11.3.3. Analysisby Scale of Operation
11.3.4. Analysisby Location of Headquarters
11.3.5. Analysisby Location of Fill / Finish Facilities
11.4. Global Installed Fill / Finish Capacity(by Volume)
11.4.1. Analysisby Type of Packaging
11.4.2. Analysisby Size of Manufacturer
11.4.3. Analysisby Scale of Operation
11.4.4. Analysisby Location of Headquarters
11.4.5. Analysisby Location of Fill / Finish Facilities
11.5. Global Installed Fill / Finish Capacityfor Ampoules (by Number of Units)
11.5.1 Analysisby Size of Manufacturer
11.5.2 Analysisby Scale of Operation
11.5.3. Analysisby Location of Headquarters
11.5.4 Analysisby Location of Fill / Finish Facilities
11.6. Global Installed Fill / Finish Capacityfor Ampoules (by Volume)
11.6.1. Analysisby Size of Manufacturer
11.6.2. Analysisby Scale of Operation
11.6.3. Analysisby Location of Headquarters
11.6.4. Analysisby Location of Fill / Finish Facilities
11.7. Global Installed Fill / Finish Capacityfor Cartridges (by Number of Units)
11.7.1. Analysisby Size of Manufacturer
11.7.2. Analysisby Scale of Operation
11.7.3. Analysisby Location of Headquarters
11.7.4. Analysisby Location of Fill / Finish Facilities
11.8. Global Installed Fill / Finish Capacityfor Cartridges (by Volume)
11.8.1. Analysisby Size of Manufacturer
11.8.2. Analysisby Scale of Operation
11.8.3. Analysisby Location of Headquarters
11.8.4. Analysisby Location of Fill / Finish Facilities
11.9. Global Installed Fill / Finish Capacityfor Syringes (by Number of Units)
11.9.1 Analysisby Size of Manufacturer
11.9.2 Analysisby Scale of Operation
11.9.3. Analysisby Location of Headquarters
11.9.4 Analysisby Location of Fill / Finish Facilities
11.10. Global Installed Fill / Finish Capacity forSyringes (by Volume)
11.10.1. Analysisby Size of Manufacturer
11.10.2. Analysisby Scale of Operation
11.10.3. Analysisby Location of Headquarters
11.10.4. Analysisby Location of Fill / Finish Facilities
11.11. Global Installed Fill / Finish Capacity forVials (by Number of Units)
11.11.1 Analysisby Size of Manufacturer
11.11.2 Analysisby Scale of Operation
11.11.3. Analysisby Location of Headquarters
11.11.4. Analysisby Location of Fill / Finish Facilities
11.12. Global Installed Fill / Finish Capacity forVials (by Volume)
11.12.1. Analysisby Size of Manufacturer
11.12.2. Analysisby Scale of Operation
11.12.3. Analysisby Location of Headquarters
11.12.4. Analysisby Location of Fill / Finish Facilities
11.13. Conclusion
12. DEMANDANALYSIS
12.1. Chapter Overview
12.2. Assumptionsand Methodology
12.3. Global Demand for Biologics Fill / FinishServices
12.3.1. Analysisby Type of Packaging
12.3.2. Analysisby Type of Biologic
12.3.3. Analysisby Therapeutic Area
12.3.4. Analysisby Geographical Location
12.4. Demandand Supply Analysis
13. BIOLOGICSMANUFACTURING AND FILL / FINISH: KEY PERFORMANCE INDICATORS
13.1. ChapterOverview
13.2. BiologicsManufacturing and Fill / Finish: Types of Key Performance Indicators
13.2.1. FinancialIndicators
13.2.1.1. BigPharma Perspective
13.2.1.2. Contract Manufacturers’Perspective
13.2.2. Processand Capability Indicators
13.2.2.1. BigPharma Perspective
13.2.2.2. ContractManufacturers’ Perspective
13.2.3. MarketReputation Indicators
13.2.3.1. BigPharma Perspective
13.2.3.2. ContractManufacturers’ Perspective
13.2.4. OtherImportant Performance Indicators
13.3.5. Conclusion
14. MARKETSIZING AND OPPORTUNITY ANALYSIS
14.1. ChapterOverview
14.2. ForecastMethodology
14.3. OverallBiologics Fill / Finish Services Market, 2019-2030
14.3.1. BiologicsFill / Finish Services Market, 2019-2030: Distribution by Type of Packaging
14.3.2. BiologicsFill / Finish Services Market, 2019-2030: Distribution by Scale of Operation
14.3.3. BiologicsFill / Finish Services Market, 2019-2030: Distribution by Type of Biologic
14.3.4. BiologicsFill / Finish Services Market, 2019-2030: Distribution by Therapeutic Area
14.3.5. BiologicsFill / Finish Services Market, 2019-2030: Distribution by Geographical Region
14.3.5.1 BiologicsFill / Finish Services Market in North America, 2019-2030: Distribution byCountries
14.3.5.2. BiologicsFill / Finish Services Market in North America, 2019-2030: Distribution by Typeof Packaging
14.3.5.3. BiologicsFill / Finish Services Market in North America, 2019-2030: Distribution byScale of Operation
14.3.5.4. BiologicsFill / Finish Services Market in North America, 2019-2030: Distribution by Typeof Biologic
14.3.5.5. BiologicsFill / Finish Services Market in North America, 2019-2030: Distribution byTherapeutic Area
14.3.5.6. BiologicsFill / Finish Services Market in Europe, 2019-2030: Distribution by Countries
14.3.5.7. BiologicsFill / Finish Services Market in Europe, 2019-2030: Distribution by Type ofPackaging
14.3.5.8. BiologicsFill / Finish Services Market in Europe, 2019-2030: Distribution by Scale ofOperation
14.3.5.9. BiologicsFill / Finish Services Market in Europe, 2019-2030: Distribution by Type ofBiologic
14.3.5.10. BiologicsFill / Finish Services Market in Europe, 2019-2030: Distribution by TherapeuticArea
14.3.5.11. BiologicsFill / Finish Services Market in Asia Pacific, 2019-2030: Distribution byCountries
14.3.5.12. BiologicsFill / Finish Services Market in Asia Pacific, 2019-2030: Distribution by Typeof Packaging
14.3.5.13. BiologicsFill / Finish Services Market in Asia Pacific, 2019-2030: Distribution by Scaleof Operation
14.3.5.14. BiologicsFill / Finish Services Market in Asia Pacific, 2019-2030: Distribution by Typeof Biologic
14.3.5.15. BiologicsFill / Finish Services Market in Asia Pacific, 2019-2030: Distribution byTherapeutic Area
14.4. BiologicsFill / Finish Services Market for Ampoules, 2019-2030
14.4.2. BiologicsFill / Finish Services Market for Ampoules, 2019-2030: Distribution by Scale ofOperation
14.4.2. BiologicsFill / Finish Services Market for Ampoules, 2019-2030: Distribution by Type ofBiologic
14.4.3. BiologicsFill / Finish Services Market for Ampoules, 2019-2030: Distribution byTherapeutic Area
14.4.4. BiologicsFill / Finish Services Market for Ampoules, 2019-2030: Distribution byGeographical Region
14.4.4.1. BiologicsFill / Finish Services Market for Ampoules in North America, 2019-2030:Distribution by Scale of Operation
14.4.4.2. BiologicsFill / Finish Services Market for Ampoules in North America, 2019-2030:Distribution by Type of Biologic
14.4.4.3. BiologicsFill / Finish Services Market for Ampoules in North America, 2019-2030:Distribution by Therapeutic Area
14.4.4.4. BiologicsFill / Finish Services Market for Ampoules in Europe, 2019-2030: Distributionby Scale of Operation
14.4.4.5. BiologicsFill / Finish Services Market for Ampoules in Europe, 2019-2030: Distributionby Type of Biologic
14.4.4.6. BiologicsFill / Finish Services Market for Ampoules in Europe, 2019-2030: Distributionby Therapeutic Area
14.4.4.7. BiologicsFill / Finish Services Market for Ampoules in Asia Pacific, 2019-2030:Distribution by Scale of Operation
14.4.4.8. BiologicsFill / Finish Services Market for Ampoules in Asia Pacific, 2019-2030:Distribution by Type of Biologic
14.4.4.9. BiologicsFill / Finish Services Market for Ampoules in Asia Pacific, 2019-2030:Distribution by Therapeutic Area
14.5. BiologicsFill / Finish Services Market for Cartridges, 2019-2030
14.5.1. BiologicsFill / Finish Services Market for Cartridges, 2019-2030: Distribution by Scaleof Operation
14.5.2. BiologicsFill / Finish Services Market for Cartridges, 2019-2030: Distribution by Typeof Biologic
14.5.3. BiologicsFill / Finish Services Market for Cartridges, 2019-2030: Distribution byTherapeutic Area
14.5.4. BiologicsFill / Finish Services Market for Cartridges, 2019-2030: Distribution byGeographical Region
14.5.4.1. BiologicsFill / Finish Services Market for Cartridges in North America, 2019-2030:Distribution by Scale of Operation
14.5.4.2. BiologicsFill / Finish Services Market for Cartridges in North America, 2019-2030:Distribution by Type of Biologic
14.5.4.3. BiologicsFill / Finish Services Market for Cartridges in North America, 2019-2030:Distribution by Therapeutic Area
14.5.4.4. BiologicsFill / Finish Services Market for Cartridges in Europe, 2019-2030: Distributionby Scale of Operation
14.5.4.5. BiologicsFill / Finish Services Market for Cartridges in Europe, 2019-2030: Distributionby Type of Biologic
14.5.4.6. BiologicsFill / Finish Services Market for Cartridges in Europe, 2019-2030: Distributionby Therapeutic Area
14.5.4.7. BiologicsFill / Finish Services Market for Cartridges in Asia Pacific, 2019-2030:Distribution by Scale of Operation
14.5.4.8. BiologicsFill / Finish Services Market for Cartridges in Asia Pacific, 2019-2030:Distribution by Type of Biologic
14.5.4.9. BiologicsFill / Finish Services Market for Cartridges in Asia Pacific, 2019-2030:Distribution by Therapeutic Area
14.6. BiologicsFill / Finish Services Market for Syringes, 2019-2030
14.6.1. BiologicsFill / Finish Services Market for Syringes, 2019-2030: Distribution by Scale ofOperation
14.6.2. BiologicsFill / Finish Services Market for Syringes, 2019-2030: Distribution by Type ofBiologic
14.6.3. BiologicsFill / Finish Services Market for Syringes, 2019-2030: Distribution byTherapeutic Area
14.6.4. BiologicsFill / Finish Services Market for Syringes, 2019-2030: Distribution byGeographical Region
14.6.4.1. BiologicsFill / Finish Services Market for Syringes in North America, 2019-2030:Distribution by Scale of Operation
14.6.4.2. BiologicsFill / Finish Services Market for Syringes in North America, 2019-2030:Distribution by Type of Biologic
14.6.4.3. BiologicsFill / Finish Services Market for Syringes in North America, 2019-2030:Distribution by Therapeutic Area
14.6.4.4. BiologicsFill / Finish Services Market for Syringes in Europe, 2019-2030: Distributionby Scale of Operation
14.6.4.5. BiologicsFill / Finish Services Market for Syringes in Europe, 2019-2030: Distributionby Type of Biologic
14.6.4.6. BiologicsFill / Finish Services Market for Syringes in Europe, 2019-2030: Distributionby Therapeutic Area
14.6.4.7. BiologicsFill / Finish Services Market for Syringes in Asia Pacific, 2019-2030:Distribution by Scale of Operation
14.6.4.8. BiologicsFill / Finish Services Market for Syringes in Asia Pacific, 2019-2030:Distribution by Type of Biologic
14.6.4.9. BiologicsFill / Finish Services Market for Syringes in Asia Pacific, 2019-2030:Distribution by Therapeutic Area
14.7. BiologicsFill / Finish Services Market for Vials, 2019-2030
14.7.1. BiologicsFill / Finish Services Market for Vials, 2019-2030: Distribution by Scale ofOperation
14.7.2. BiologicsFill / Finish Services Market for Vials, 2019-2030: Distribution by Type ofBiologic
14.7.3. BiologicsFill / Finish Services Market for Vials, 2019-2030: Distribution by TherapeuticArea
14.7.4. BiologicsFill / Finish Services Market for Vials, 2019-2030: Distribution byGeographical Region
14.7.4.1. BiologicsFill / Finish Services Market for Vials in North America, 2019-2030:Distribution by Scale of Operation
14.7.4.2. BiologicsFill / Finish Services Market for Vials in North America, 2019-2030:Distribution by Type of Biologic
14.7.4.3. BiologicsFill / Finish Services Market for Vials in North America, 2019-2030:Distribution by Therapeutic Area
14.7.4.4. BiologicsFill / Finish Services Market for Vials in Europe, 2019-2030: Distribution byScale of Operation
14.7.4.5. BiologicsFill / Finish Services Market for Vials in Europe, 2019-2030: Distribution byType of Biologic
14.7.4.6. BiologicsFill / Finish Services Market for Vials in Europe, 2019-2030: Distribution byTherapeutic Area
14.7.4.7. BiologicsFill / Finish Services Market for Vials in Asia Pacific, 2019-2030:Distribution by Scale of Operation
14.7.4.8. BiologicsFill / Finish Services Market for Vials in Asia Pacific, 2019-2030:Distribution by Type of Biologic
14.7.4.9. BiologicsFill / Finish Services Market for Vials in Asia Pacific, 2019-2030:Distribution by Therapeutic Area
15. FUTUREGROWTH OPPORTUNITIES
15.1. ChapterOverview
15.2. GrowingBiopharmaceutical Pipeline
15.3. Increasein Outsourcing Fill / Finish Activities
15.4. RisingFocus on Self-Administration
15.5. Advancesin Aseptic Fill / Finish Technologies
15.6. GrowingOpportunities in the Asia-Pacific Region
16. CASESTUDY: ROBOTIC SYSTEMS IN FILL / FINISH OPERATIONS
16.1. ChapterOverview
16.2. ContractService Providers: List of Fill / Finish Equipment
16.3. Role ofRobotic Systems in Fill / FinishOperations
16.3.1. Types ofRobots Used in Pharmaceutical Operations
16.3.2. KeyConsiderations for Selecting a Robotic System
16.3.3. Advantagesof Robotic Systems
16.3.4. Disadvantagesof Robotic Systems
16.4. CompaniesProviding Robots for Use in the Pharmaceutical Industry
16.5. ConcludingRemarks
17. CASESTUDY: READY-TO-USE PACKAGING COMPONENTS IN ASEPTIC FILL / FINISH OPERATIONS
17.1. ChapterOverview
17.2. Role ofReady-to-Use Packaging Components in Aseptic Fill / Finish Operations
17.2.1. Advantagesof Ready-to-Use Packaging Components
17.2.2. Disadvantagesof Ready-to-Use Packaging Components
17.3. CompaniesProviding Ready-to-Use Packaging Components
17.4. ConcludingRemarks
18. CONCLUDINGREMARKS
18.1. ChapterOverview
18.2. KeyTakeaways
19. INTERVIEWTRANSCRIPTS
19.1 ChapterOverview
19.2 HALIX
19.2.1 InterviewTranscript: Jos Vergeest, International Business Developer
19.3 IDTBiologika
19.3.1. InterviewTranscript: Gregor Kawaletz, Chief Commercial Officer
19.4 oncomedmanufacturing
19.4.1 InterviewTranscript: Ales Sima, Business Development Manager
19.5. Syngene
19.5.1 InterviewTranscript: Purushottam Singnurkar, Research Director and Head of FormulationDevelopment
20. APPENDIX1: TABULATED DATA
21. APPENDIX2: LIST OF COMPANIES AND ORGANIZATIONS
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
